Eli Lilly

Forbes - Apr 25th, 2025
Score 6.0

Big Pharma Is Investing Billions In AI— And The Value Is Finally Starting To Show

AI revolutionizes pharma with faster drug discovery and development.

Npr - Apr 23rd, 2025
Score 8.2

Eli Lilly sues companies selling alternative versions of its weight loss drug

Eli Lilly sues telehealth firms over illegal Zepbound drug copies.

New York Post - Apr 13th, 2025
Score 7.6

Senator John Fetterman explains how GLP-1 drugs changed his life

Sen. Fetterman champions wider access to GLP-1 drugs after personal health success

Tech Crunch - Mar 31st, 2025
Score 7.4

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs raises $600M to boost AI-driven drug discovery innovations.

New York Post - Mar 31st, 2025
Score 7.4

Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business

Google's Isomorphic Labs raises $600M to revolutionize drug discovery with AI

Forbes - Mar 26th, 2025
Score 7.2

Which Side Will Makary Take In The Fight Over Weight Loss Drugs?

FDA's New Chief Faces Controversy Over Weight Loss Drug Compounding Battle

Npr - Mar 19th, 2025
Score 6.4

Patients scramble as cheaper obesity drug alternatives disappear

FDA halts compounded obesity drug, patients scramble amid Zepbound shortage resolution

Forbes - Jan 20th, 2025
Score 6.6

2 Corporate VC Models To Fuel Unicorn Success In Emerging Industries

Andreessen Horowitz, Eli Lilly redefine corporate venture with Biotech Ecosystem Fund.

Previous Next

Showing 1 to 8 of 8 results